|
gptkbp:instance_of
|
gptkb:Trade_Federation
|
|
gptkbp:advocates_for
|
research funding
patient access to medications
sustainable healthcare solutions
biopharmaceutical research
|
|
gptkbp:aims_to
|
improve public health
|
|
gptkbp:collaborates_with
|
government agencies
academic institutions
|
|
gptkbp:conducts
|
research on drug pricing
|
|
gptkbp:conducts_surveys_on
|
drug development costs
|
|
gptkbp:engages_in
|
public relations campaigns
lobbying activities
|
|
gptkbp:focuses_on
|
innovation in drug development
|
|
gptkbp:founded
|
gptkb:1958
|
|
gptkbp:full_name
|
gptkb:Pharmaceutical_Research_and_Manufacturers_of_America
|
|
gptkbp:governed_by
|
a board of directors
|
|
gptkbp:has_a_focus_on
|
rare diseases
|
|
gptkbp:has_a_website
|
www.phrma.org
|
|
gptkbp:has_mission
|
advance medical innovation
|
|
gptkbp:has_partnerships_with
|
patient organizations
|
|
gptkbp:has_role
|
shaping healthcare policy
|
|
gptkbp:headquartered_in
|
gptkb:the_United_States
|
|
gptkbp:headquarters
|
gptkb:Washington,_D._C.
|
|
gptkbp:hosts
|
conferences and events
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ph RMA
|
|
gptkbp:industry
|
gptkb:pharmaceuticals
|
|
gptkbp:initiatives
|
gptkb:biotechnology
gptkb:healthcare_access
|
|
gptkbp:is_a_member_of
|
gptkb:the_U._S._Chamber_of_Commerce
|
|
gptkbp:is_a_resource_for
|
gptkb:healthcare_professionals
|
|
gptkbp:is_a_source_of
|
industry statistics
|
|
gptkbp:is_committed_to
|
patient safety
|
|
gptkbp:is_focused_on
|
drug safety and efficacy.
|
|
gptkbp:is_influential_in
|
the pharmaceutical landscape
|
|
gptkbp:is_involved_in
|
gptkb:healthcare_reform
patient advocacy
global health issues
patient-centered care initiatives
international drug regulation
|
|
gptkbp:is_known_for
|
its lobbying efforts
|
|
gptkbp:is_recognized_as
|
a leading voice in the pharmaceutical industry
|
|
gptkbp:key_player
|
the healthcare ecosystem
|
|
gptkbp:leadership
|
pharmaceutical research advocacy
|
|
gptkbp:legislation
|
drug affordability
|
|
gptkbp:members
|
pharmaceutical companies
|
|
gptkbp:offers
|
gptkb:educational_programs
|
|
gptkbp:participates_in
|
healthcare policy discussions
|
|
gptkbp:promotes
|
intellectual property rights
|
|
gptkbp:provides
|
policy analysis
|
|
gptkbp:provides_guidance_on
|
clinical trial regulations
|
|
gptkbp:provides_information_on
|
drug approval processes
pharmaceutical industry trends
|
|
gptkbp:publishes
|
gptkb:educational_materials
|
|
gptkbp:released
|
annual reports
|
|
gptkbp:supports
|
clinical trials
|
|
gptkbp:was_a_proponent_of
|
biopharmaceutical innovation
|
|
gptkbp:works_to
|
enhance drug discovery
|
|
gptkbp:works_with
|
research institutions
|
|
gptkbp:bfsParent
|
gptkb:Eli_Lilly
gptkb:GSK
|
|
gptkbp:bfsLayer
|
4
|